Anti-alpha-synuclein antibodies
US12410244B2 · kind B2 · utility
0Cited by
27References
15Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 28, 2022 |
| Grant date | Sep 9, 2025 |
| Priority date | — |
| Expiry date | Jun 15, 2044 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/94
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to alpha synuclein binding antibodies and fragments thereof capable of binding alpha synuclein as a monomer and in fibrils and preventing alpha synuclein aggregation induced by alpha synuclein fibrils. The antibodies of the present invention are for use in the treatment of alpha synucleinopathies, including Parkinson's disease.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.